Posted on August 10, 2020 by adminProtalix BioTherapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production … ( read original story …)